Physician profile
Mitchell Christopher Weaver
NPI 1093343485
$6,867.20
in general payments reported to CMS, 2019-2025
11 companies · $3,764 in 2025
The $3,764 reported for 2025 was more than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $39.59 · 2021: $771 · 2022: $501 · 2023: $722 · 2024: $1,070 · 2025: $3,764.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,857 · Grant: $2,500 · Education: $199.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,857.00 |
| Grant | $2,500.00 |
| Education | $198.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $2,620.28 | 2025 | Real Intelligence |
| Stryker Corporation | $2,061.05 | 2021-2025 | Mako, Triathlon, T2 |
| Depuy Synthes Sales INC. | $1,489.02 | 2020-2025 | Na, Velys, Attune |
| Acumed LLC | $150.00 | 2021 | |
| Medical Device Business Services, INC. | $143.00 | 2021-2024 | Na |
| Linkbio Corp | $141.92 | 2025 | |
| Bioventus LLC | $120.39 | 2024 | Exogen Ultrasound Bone Healing System |
| Zimmer Biomet Holdings, INC. | $54.44 | 2025 | Tapestry |
| Lightbody Medical Technologies INC | $52.99 | 2025 | |
| Vertex Pharmaceuticals Incorporated | $19.13 | 2025 | |
| Orthofix Medical, INC. | $14.98 | 2024 | Physio-Stim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mitchell Weaver listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.